International Stem Cell CORP (ISCO) Financial Statements (2024 and earlier)

Company Profile

Business Address 5950 PRIESTLY DRIVE
CARLSBAD, CA 92008
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,382943742666586398
Cash and cash equivalents1,382943742666586398
Receivables662688747427663902
Inventory, net of allowances, customer advances and progress billings1,2961,2941,3841,4151,3611,322
Inventory1,2961,2941,3841,4151,3611,322
Prepaid expense213285    
Other current assets3226 5363 
Other undisclosed current assets99 90139321338
Total current assets:3,6843,2362,9632,7002,9942,960
Noncurrent Assets
Inventory, Noncurrent326295286369359390
Operating lease, right-of-use asset646687727764800835
Property, plant and equipment256232248279313348
Intangible assets, net (including goodwill)837858878896917933
Intangible assets, net (excluding goodwill)837858878896917933
Other undisclosed noncurrent assets373333343335
Total noncurrent assets:2,1022,1052,1722,3422,4222,541
TOTAL ASSETS:5,7865,3415,1355,0425,4165,501
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8529838308539781,140
Accounts payable331351322378477635
Accrued liabilities521632508475501505
Debt3,390     
Due to related parties3,3573,3253,2913,2583,225
Other undisclosed current liabilities502491480469458446
Total current liabilities:4,7444,8314,6354,6134,6944,811
Noncurrent Liabilities
Long-term debt and lease obligation:    781840896
Liabilities, other than long-term debt588656720   
Operating lease, liability588656720781840896
Other undisclosed noncurrent liabilities    (781)(840)(896)
Total noncurrent liabilities:588656720781840896
Total liabilities:5,3325,4875,3555,3945,5345,707
Equity
Equity, attributable to parent, including:(3,846)(4,446)(4,520)(4,652)(4,418)(4,506)
Common stock888888
Additional paid in capital106,028105,920105,812105,703105,594105,504
Accumulated deficit(109,887)(110,379)(110,345)(110,368)(110,025)(110,023)
Other undisclosed equity, attributable to parent555555
Other undisclosed equity4,3004,3004,3004,3004,3004,300
Total equity:454(146)(220)(352)(118)(206)
TOTAL LIABILITIES AND EQUITY:5,7865,3415,1355,0425,4165,501

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues1,8412,0862,4301,7032,0272,020
Cost of revenue(713)(824)(1,136)(690)(718)(725)
Gross profit:1,1281,2621,2941,0131,3091,295
Operating expenses(1,272)(1,260)(1,233)(1,313)(1,278)(1,270)
Operating income (loss):(144)261(300)3125
Nonoperating income (expense)636(36)(38)(43)(33) 
Other nonoperating income (expense) 671 (5)(8)  
Interest and debt expense(35)(36)(37)(33) (32)
Income (loss) from continuing operations:457(70)(14)(376)(2)(7)
Loss before gain (loss) on sale of properties:(376)(2)(7)
Other undisclosed net income (loss)  3637  (2)
Net income (loss):457(34)23(376)(2)(9)
Other undisclosed net income attributable to parent35  33  
Net income (loss) attributable to parent:492(34)23(343)(2)(9)
Undistributed earnings (loss) allocated to participating securities, basic (233)     
Net income (loss) available to common stockholders, diluted:259(34)23(343)(2)(9)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):457(34)23(376)(2)(9)
Comprehensive income (loss), net of tax, attributable to parent:457(34)23(376)(2)(9)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: